Frick et al. (2018) confirmed previous reports of reduced C9orf72 protein levels in the cerebellum of C9orf72 mutation carriers with no association to clinical phenotypes (ALS, ALS/FTD or FTD), age at onset and disease duration [16]. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.